Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Upstream Bio Inc.

    NASDAQ: UPB · Real-Time Price · USD
    11.35
    -0.21 (-1.82%)
    At close: Jun 13, 2025, 3:59 PM
    11.41
    0.53%
    After-hours: Jun 13, 2025, 06:48 PM EDT

    Upstream Bio Statistics

    Share Statistics

    Upstream Bio has 53.79M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 53.79M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 2,714

    FTD / Avg. Volume

    n/a
    		 0.83%

    Short Selling Information

    The latest short interest is 3.69M, so 6.85% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.69M

    Short % of Shares Out

    n/a
    		 6.85%

    Short % of Float

    n/a
    		 12.39%

    Short Ratio (days to cover)

    n/a
    		 9.55

    Valuation Ratios

    The PE ratio is -13.44 and the forward PE ratio is -3.96. Upstream Bio's PEG ratio is 0.13.

    PE Ratio

    n/a
    		 -13.44

    Forward PE

    n/a
    		 -3.96

    PS Ratio

    n/a
    		 356.14

    Forward PS

    n/a
    		 34.9

    PB Ratio

    n/a
    		 1.8

    P/FCF Ratio

    n/a
    		 -14.14

    PEG Ratio

    n/a
    		 0.13
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Upstream Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 44.63, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 44.63

    Quick Ratio

    n/a
    		 44.63

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $45,576.92

    Profits Per Employee

    n/a
    		 $-1,207,807.69

    Employee Count

    n/a
    		 52

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.6, so Upstream Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.6

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 9.01

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 67.14

    Average Volume (20 Days)

    n/a
    		 328,501

    Income Statement

    In the last 12 months, Upstream Bio had revenue of 2.37M and earned -62.81M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 2.37M

    Gross Profit

    n/a
    		 2.37M

    Operating Income

    n/a
    		 -77.76M

    Net Income

    n/a
    		 -62.81M

    EBITDA

    n/a
    		 -77.67M

    EBIT

    n/a
    		 -77.76M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 325.89M in cash and 1.83M in debt, giving a net cash position of 324.06M.

    Cash & Cash Equivalents

    n/a
    		 325.89M

    Total Debt

    n/a
    		 1.83M

    Net Cash

    n/a
    		 324.06M

    Retained Earnings

    n/a
    		 -190.78M

    Total Assets

    n/a
    		 456.17M

    Working Capital

    n/a
    		 444.22M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -59.17M and capital expenditures -511K, giving a free cash flow of -59.68M.

    Operating Cash Flow

    n/a
    		 -59.17M

    Capital Expenditures

    n/a
    		 -511K

    Free Cash Flow

    n/a
    		 -59.68M

    FCF Per Share

    n/a
    		 -1.16
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -3281.18% and -2650.04%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -3281.18%

    Pretax Margin

    n/a
    		 -2650.04%

    Profit Margin

    n/a
    		 -2650.04%

    EBITDA Margin

    n/a
    		 -3277.43%

    EBIT Margin

    n/a
    		 -3281.18%

    FCF Margin

    n/a
    		 -2518.27%

    Dividends & Yields

    UPB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for UPB is $56.5, which is 397.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $56.5

    Price Target Difference

    n/a
    		 397.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 28.4

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist